SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: Fred Puppet who wrote (1832)3/16/1999 5:54:00 PM
From: Jon Koplik  Read Replies (2) | Respond to of 2135
 
Don't forget that "the experts at Bristol-Myers Squibb" also "dismissed" the use of Thalidomide in treating cancer, and then someone else took it up, and it is now being sold like hotcakes and saving cancer patients' lives.

(And, no, I have not personally worked with these various drugs, but I can read the news with an open mind).

Jon.



To: Fred Puppet who wrote (1832)3/16/1999 8:00:00 PM
From: David Winkler  Read Replies (1) | Respond to of 2135
 
Entremed is making both angiostatin and endostatin using a different system. It is working and they are making it in quantities needed for trials (unless you think they are lying). Many people tried to build air planes and failed. The Wright Brothers were successful, and look where we are now!!



HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News